Pluripotent stem cell therapy

Anna Veiga Lluch

POSTDOCTORAL RESEARCHERS
  • Begoña Aran Corbella
SCIENTIFIC SUPPORT
  • Bernd Kuebler
  • Silvia Emilia Selvitella Luna
MANAGEMENT SUPPORT
  • Anuska Linares Baraza
Regenerative Medicine
Regenerative Medicine

Scientific production

4

PAPERS

Average IF: 11,13

LED PAPERS

2 PUBLICATIONS IN FIRST QUARTILE

4 PUBLICATIONS IN FIRST QUARTILE

4 PUBLICATIONS IN OPEN ACCESS

Selected publications

  • Roncero Carol,J;Olaizola Munoa,J;Aran,B;Mularoni,LS;Cuesta,MM;Blanco Cabra,N;Casals,M et al, Epithelial cells provide immunocompetence to the early embryo for bacterial clearance, Cell Host Microbe, 2025;33(7):1106-1120, doi:10.1016/j.chom.2025.05.025
  • Godeau,AL;Seriola,A;Tchaicheeyan,O;Casals,M;Denkova,D;Aroca,E;Massafret,OT et al, Traction force and mechanosensitivity mediate species-specific implantation patterns in human and mouse embryos, Sci Adv, 2025;11(33):doi:10.1126/sciadv.adr5199
  • Catasus,N;Casals Sendra,G;Torres Martin,M;Rosas,I;Kuebler,B;Mazuelas,H;Amilibia,E et al, iPSC-based merlin-deficient Schwann cell-like spheroids as an in vitro system for studying NF2 pathogenesis, Genes Dis, 2025;12(6):101615-101615, doi:10.1016/j.gendis.2025.101615
  • Boada Pladellorens,A;Avellanet,M;Veiga,A;Pages Bolibar,E, Efficacy of Stromal Vascular Fraction Treatment for Knee Osteoarthritis: A Single-Arm Experimental Trial., Biomedicines, 2025;13(12):doi:10.3390/biomedicines13122913

Research highlights

PROJECTS

3 Ongoing competitive projects

NETWORKS

SGR GRC-2021
HAPLO-iPS

Selected projects

  • PI21/01122. Edición genómica mediante CRISPR/Cas9 en embriones humanos para el estudio del desarrollo embrionario temprano. EMBRYOCRISPR. Instituto de Salud Carlos III (ISCIII). Budget: 155.520,4€. 2022-2025. PI: ANA VEIGA LLUCH.
  • CA21151. HAPLO-iPS: GENERATION OF HUMAN INDUCED PLURIPOTENT STEM CELLS FROM HAPLO-SELECTED CORD BLOOD SAMPLES. COST ASSOCIATION. Budget: 690,499,96€. 2022-2026. PI: ANA VEIGA LLUCH.
  • PT23/00092. Plataforma ISCIII de BioBancos y Biomodelos: Unidad Banco de Líneas Celulares de IDIBELL. Instituto de Salud Carlos III. Budget: 226.954€. 2024-2026. PI: ANA VEIGA LLUCH.